RE: RNS OUT8 Oct 2021 16:09
My take fwiw is the market has over-reacted to the company withdrawing guidance for 2021. It's understandable when one considers the financing is what's required to meet that guidance. Having said this it's always going to go down like a lead balloon, especially if you're not getting an inkling of what will be possible by year-end. Market hates uncertainty. Otherwise everything is looking much better and a huge amount of progress has been made. Highlights include another stope is opened next month, and this will be doubled to 4 in December. This de-risks the operational side of things (funding aside), and means they can maintain a higher head grade, copper production etc. They also confirmed the hedge will be cleared this year. This was the second major anchor on the share price, after funding, which is positive. The drawback if when full production throughput will be reached, which again relies on the financing. They have grown throughput alongside copper produced, but still need to double the tonnage if they want to hit full production - is this possible, and by when? They are managing the impact of Covid, which bodes well for the Winter months. The ore sorter feasibility looks like a dead certainty to progress given the significant incremental gains in copper, gold and silver that will be produced. We should also get assay results soon, which one would expect to be quite strong given recent successes.
So the big one is they need to close the financing. This means they can provide year-end guidance (good or bad), and more importantly guidance for H1 2022. It also means they can focus solely on getting the throughput maximized and making the most of the higher head grade as more stopes are opened. Reading between the lines it sounds as though they've hit a stumbling block and are applying pressure to the lenders to get their act together. They can of course draw down on the credit card, which isn't ideal. Or they can do a modest capital raise. Both will mean they need to borrow less, which in some ways will put two fingers up to the financing partners who are f@cking them around.
Hopefully financing sorted in the coming weeks and the re-rate to 25-30p can happen. It would be great if this was closely followed by some strong assays, which will support the share price should year end guidance be a disappointment. With financing, strong assays, hedge cleared, 4 stopes opened in December, plus a promise of profitability in Q1, I can see us back to +30p in a flash. I do believe all of these things will happen so will continue to accumulate now and on any weakness. Holding 300k currently. AIMHO. GLA.